Gerald D. Laubach
No más puestos en curso
Perfil
Gerald D.
Laubach, Ph.D., aged 78 years, has been the director of the Company since September 2002.
Dr. Laubach was President of Pfizer, Inc. from 1972 to 1990.
He is a member of the Institute of Medicine and the National Academy of Engineering.
He is a former director of Cigna Corporation, Pfizer Inc., Millipore Corporation and several biotechnology firms.
Dr. Laubach received a B.A.
from the University of Pennsylvania and a Ph.D.
in organic chemistry from the Massachusetts Institute of Technology.
Antiguos cargos conocidos de Gerald D. Laubach.
| Empresas | Cargo | Fin |
|---|---|---|
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 17/03/2006 |
Formación de Gerald D. Laubach.
| University of Pennsylvania | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Gerald D. Laubach
